Gene therapy of liver diseases: a 2011 perspective

Gloria Gonzalez-Aseguinolaza1, Jesús Prieto

  • 1Division of Hepatology and Gene Therapy, Centro de Investigación Medica Aplicada and Clinica Universitaria, University of Navarra, Pamplona, Spain.

Insights

Gene therapy offers a promising new approach for treating liver diseases, including cancer and inherited disorders, where current treatments are limited. Recent advancements suggest gene therapy may soon become a standard option for various liver conditions.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Medical Genetics

Background:

  • Liver diseases pose significant global health challenges due to high prevalence and limited therapeutic options.
  • Current treatments for conditions like cirrhosis, viral hepatitis, and liver cancer have notable limitations.
  • Gene therapy has emerged as a novel therapeutic strategy since the 1990s.

Purpose of the Study:

  • To review the potential of gene therapy for managing liver diseases.
  • To highlight recent successes and future prospects of gene therapy in hepatology.
  • To explore gene therapy as an alternative for incurable liver conditions.

Main Methods:

  • Literature review of gene therapy applications in liver disease.
  • Analysis of recent clinical successes and ongoing research in the field.
  • Synthesis of information on gene transfer techniques for therapeutic purposes.

Main Results:

  • Gene therapy has shown success in treating other severe genetic disorders, indicating its potential for liver diseases.
  • Recent advancements suggest gene therapy is moving towards becoming a standard therapeutic option.
  • The review illustrates the significant potential of gene therapy for liver conditions lacking effective treatments.

Conclusions:

  • Gene therapy represents a promising frontier for treating a wide range of liver diseases.
  • Further research and clinical application of gene therapy could revolutionize liver disease management.
  • The potential for gene therapy to address unmet needs in liver disease is substantial.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...